Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials
about
Acetylsalicylic acid (aspirin) for schizophreniaCytokines in Schizophrenia: Hope or Hype?The role of inflammation in schizophreniaThe cytokine model of schizophrenia: emerging therapeutic strategiesInflammation and schizophreniaPostmortem evidence of cerebral inflammation in schizophrenia: a systematic reviewEfficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an updateA multispecies approach for understanding neuroimmune mechanisms of stress.Immunological aspects of the treatment of depression and schizophrenia.A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis.Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation.Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.The spectrum of psychosis in multiple sclerosis: a clinical case seriesEmerging drugs for schizophrenia: an update.Drug repurposing and emerging adjunctive treatments for schizophrenia.Glutamatergic agents for schizophrenia: current evidence and perspectives.Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries.Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.Personalized medicine in psychiatry.Abnormalities in chemokine levels in schizophrenia and their clinical correlates.In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis.Psychosis: an autoimmune disease?Concomitant NSAID use during antipsychotic treatment and risk of 2-year relapse - a population-based study of 16,253 incident patients with schizophrenia.Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein.Markers of inflammation in schizophrenia: association vs. causationThe search for new biomarkers for cognition in schizophrenia.Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review.Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance?A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia.Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression.A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.Synthesis and biological evaluation of novel flavanone derivatives as potential antipsychotic agents.Anti-inflammatory strategies in the treatment of schizophrenia.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations.Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study.
P2860
Q24186077-2B3663D4-8F67-4709-8BEF-B21A5DB1FCDDQ26750430-0C95BB8E-84C1-48BB-9BCC-9DE8BF258A4CQ26779719-5CE5CE7D-CF36-408B-8913-D0918C708954Q26865996-04949296-48D4-4105-9EEF-262929B9E25CQ27002489-F14187CC-438F-4361-857A-41DE882B68AEQ28077391-349B325E-7470-4772-BF2F-4D1852970C4CQ28299995-B9BE6E9F-3CAA-423A-84AF-5E48BC3310C9Q33721025-D936BC8A-5EA0-481A-ACB9-FE9B6311AAA2Q33721031-F6304906-82C0-4124-B21C-3C5BCF7AD0ACQ34405264-ED7C1BA6-8F9D-4A19-8C50-6F3EE3D63279Q35950801-12F880C5-6FD5-401D-B63A-67121AEF4C8AQ35968008-5D1FEE63-1881-4FB7-814C-7901D2FBF0AFQ36579965-CE8CBA72-0F9E-49E3-BDCE-B6DB0E7FA477Q37629581-D9AF0FCF-4C21-4EFE-AC99-14C30F131E2BQ38252404-7AD403D7-422D-46C5-94AE-AE1B9743689EQ38417631-AD1ACA3D-CF70-416C-9493-70693B8B0C81Q38444551-47795C5F-AF98-4779-877D-588411A0D47DQ38565570-449377BC-0F2F-4B58-A5B1-E453CEF6B5B1Q38647035-C448F3F0-EC09-436B-819D-1A61D1C3A430Q38718345-BBDBCC0D-75CD-4B72-8604-1B96C99608A1Q38809444-BC2BEE14-21C4-4AD5-B9DA-0742A438A5BBQ38937776-39E13E03-E3E3-4E44-8B4C-B3B2CA9E306CQ39075961-99C34F1E-4B79-43D4-A3DF-D4471C1F385CQ39415063-2352E616-47BC-464E-BC2B-F37430AB9E6DQ39432877-6F5E0507-CEB0-4F87-AF9D-75C92A301874Q40847189-9835448C-6A51-4D66-87C4-0BC8401902B0Q40965410-9FBDEE9B-7692-4CDA-A1D7-CF34ECC2BD3AQ42738765-7594BC00-F462-479B-A07D-3D8757DAD0F4Q43376611-9F5D310D-7765-4480-AD9B-3118A18C8973Q47152736-2065C7B9-F333-44EA-8B01-070123B3766DQ47155489-3B781766-09CA-4F93-BDE7-2B3206457AF9Q47579231-D63DB5DD-9FE9-44C3-8516-DB4BAE4FE031Q47582903-3AABD944-73B5-492B-9A97-35DCC5B1C914Q47935886-F950E2CC-3BD9-4525-82FE-AABDDEB727D6Q48063321-32C6ABA2-FFC1-4F80-BC8C-1C4B74E49A14Q48561060-0C66CB08-9C09-439F-AADB-7BF80F91D3D0Q50561727-4E39062C-ECD9-464E-9B0C-169F669874BDQ54217096-0D400F30-1ED0-46AB-9613-EAB637892CECQ54237101-E4DD1407-C7FD-4FF1-83C5-FCEFACF7BF82Q55016813-71291E7E-FA83-499E-9B5A-CFC57072BEA2
P2860
Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adjunctive use of nonsteroidal ...... f randomized controlled trials
@en
Adjunctive use of nonsteroidal ...... randomized controlled trials.
@nl
type
label
Adjunctive use of nonsteroidal ...... f randomized controlled trials
@en
Adjunctive use of nonsteroidal ...... randomized controlled trials.
@nl
prefLabel
Adjunctive use of nonsteroidal ...... f randomized controlled trials
@en
Adjunctive use of nonsteroidal ...... randomized controlled trials.
@nl
P2093
P2860
P356
P1476
Adjunctive use of nonsteroidal ...... f randomized controlled trials
@en
P2093
Christoph U Correll
Mark Weiser
Masahiro Nitta
Michael Davidson
Norbert Müller
Taishiro Kishimoto
P2860
P304
P356
10.1093/SCHBUL/SBT070
P407
P50
P577
2013-05-29T00:00:00Z